Cita APA (7a ed.)

Ino, H., Nakazawa, E., & Akabayashi, A. (2021). Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps. Cambridge quarterly of healthcare ethics, 30(1), 51-58. doi:10.1017/S0963180120000481

Cita Chicago Style (17a ed.)

Ino, Hiroyasu, Eisuke Nakazawa, y Akira Akabayashi. "Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps." Cambridge Quarterly of Healthcare Ethics 30, no. 1 (2021): 51-58, https://doi.org/10.1017/S0963180120000481.

Cita MLA (8a ed.)

Ino, Hiroyasu, et al. "Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps." Cambridge Quarterly of Healthcare Ethics, vol. 30, no. 1, 2021, pp. 51-58, https://doi.org/10.1017/S0963180120000481.

Precaución: Estas citas no son 100% exactas.